🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 165 (from laksa098)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa165.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://covid19.trackvaccines.org/country/france/\')), getAhrefsUnparsedNoserviceFromURL(\'https://covid19.trackvaccines.org/country/france/\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/covid19.trackvaccines.org\/country\/france\/","crawl_time":1775764175,"first_indexed_time":1610633016,"http_code":200,"src_unparsed":"org,trackvaccines!covid19,\/country\/france\/ s443","src_root_hash":"5896860197286366765","history_drop_reason":null,"meta_title":"France – COVID19 Vaccine Tracker","meta_descriptions":[],"attrs_boilerpipe_text":"11 Vaccines Approved for Use in France\nNovavax\nNuvaxovid\nThis vaccine is approved.\nApproved\nin 40 countries\n22 trials\nin 14 countries\nApproval Source:\nema.europa.eu\nProtein Subunit\nSanofi\/GSK\nVidPrevtyn Beta\nThis vaccine is approved.\nApproved\nin 30 countries\n3 trials\nin 2 countries\nApproval Source:\nema.europa.eu\nProtein Subunit\nModerna\nSpikevax\nThis vaccine is approved.\nApproved\nin 88 countries\n70 trials\nin 24 countries\nApproval Source:\nema.europa.eu\nRNA\nModerna\nSpikevax Bivalent Original\/Omicron BA.1\nThis vaccine is approved.\nApproved\nin 38 countries\n5 trials\nin 4 countries\nApproval Source:\nema.europa.eu\nRNA\nModerna\nSpikevax Bivalent Original\/Omicron BA.4\/BA.5\nThis vaccine is approved.\nApproved\nin 33 countries\n2 trials\nin 1 country\nApproval Source:\nema.europa.eu\nRNA\nPfizer\/BioNTech\nComirnaty\nThis vaccine is approved.\nApproved\nin 149 countries\n100 trials\nin 31 countries\nApproval Source:\nema.europa.eu\nRNA\nPfizer\/BioNTech\nComirnaty Bivalent Original\/Omicron BA.1\nThis vaccine is approved.\nApproved\nin 35 countries\n3 trials\nin 5 countries\nApproval Source:\nema.europa.eu\nRNA\nPfizer\/BioNTech\nComirnaty Bivalent Original\/Omicron BA.4\/BA.5\nThis vaccine is approved.\nApproved\nin 33 countries\n4 trials\nin 1 country\nApproval Source:\nema.europa.eu\nRNA\nJanssen (Johnson & Johnson)\nJcovden\nThis vaccine is approved.\nApproved\nin 113 countries\n26 trials\nin 25 countries\nApproval Source:\nema.europa.eu\nNon Replicating Viral Vector\nOxford\/AstraZeneca\nVaxzevria\nThis vaccine is approved.\nApproved\nin 149 countries\n73 trials\nin 34 countries\nApproval Source:\nema.europa.eu\nNon Replicating Viral Vector\nValneva\nVLA2001\nThis vaccine is approved.\nApproved\nin 33 countries\n9 trials\nin 4 countries\nApproval Source:\nema.europa.eu\nInactivated\n6 Vaccines in Clinical Trials in France\nSanofi\/GSK\nRecombinant Protein\nThis vaccine has reached Phase 3 trials.\n6 trials\nin 7 countries\nProtein Subunit\nSanofi\/GSK\nVidPrevtyn Beta\nThis vaccine is approved.\nApproved\nin 30 countries\n3 trials\nin 2 countries\nProtein Subunit\nPfizer\/BioNTech\nComirnaty\nThis vaccine is approved.\nApproved\nin 149 countries\n100 trials\nin 31 countries\nRNA\nJanssen (Johnson & Johnson)\nJcovden\nThis vaccine is approved.\nApproved\nin 113 countries\n26 trials\nin 25 countries\nNon Replicating Viral Vector\nReiThera\nGRAd-COV2\nThis vaccine has reached Phase 3 trials.\n5 trials\nin 12 countries\nNon Replicating Viral Vector\n2 Vaccines with Trials in France are No Longer Progressing\nCurevac\nCVnCoV\nThis vaccine has reached Phase 3 trials.\n9 trials\nin 12 countries\nRNA","attrs_markdown":"[Skip to Content](https:\/\/covid19.trackvaccines.org\/country\/france\/#content)\n\nThis site is no longer being updated. Data are accurate as of 2 Dec 2022.\n\n[![COVID-19 Vaccine Tracker](https:\/\/covid19.trackvaccines.org\/wp-content\/uploads\/2020\/09\/new-logo-draft.png)](https:\/\/covid19.trackvaccines.org\/)\n\nMenu\n\n- [Home](https:\/\/covid19.trackvaccines.org\/)\n- [Explore Vaccines](https:\/\/covid19.trackvaccines.org\/vaccines\/)\n  - [Approved Vaccines](https:\/\/covid19.trackvaccines.org\/vaccines\/approved\/)\n  - [Vaccine Candidates](https:\/\/covid19.trackvaccines.org\/vaccines\/)\n  - [Global Landscape](https:\/\/covid19.trackvaccines.org\/trials-vaccines-by-country\/)\n- [About Vaccines & Trials](https:\/\/covid19.trackvaccines.org\/country\/france\/)\n  - [How many types of COVID-19 vaccines are there?](https:\/\/covid19.trackvaccines.org\/vaccine-types\/)\n  - [How do COVID-19 vaccines work?](https:\/\/covid19.trackvaccines.org\/how-vaccines-work\/)\n  - [What are the benefits of COVID-19 vaccines?](https:\/\/covid19.trackvaccines.org\/benefits-of-vaccines\/)\n  - [What are the possible side effects of COVID-19 vaccines?](https:\/\/covid19.trackvaccines.org\/covid-19-vaccine-side-effects\/)\n  - [Do COVID-19 vaccines work against variants of concern?](https:\/\/covid19.trackvaccines.org\/voc\/)\n  - [Which COVID-19 vaccine should I get?](https:\/\/covid19.trackvaccines.org\/which-vaccine-to-get\/)\n  - [Do I need to get vaccinated if I’ve already had COVID-19?](https:\/\/covid19.trackvaccines.org\/already-had-covid-19\/)\n  - [How do I critically assess vaccine information?](https:\/\/covid19.trackvaccines.org\/heads\/)\n  - [How are vaccines tested?](https:\/\/covid19.trackvaccines.org\/how-are-vaccines-tested\/)\n  - [How is vaccine efficacy assessed?](https:\/\/covid19.trackvaccines.org\/vaccine-efficacy\/)\n  - [How were COVID-19 vaccines developed so quickly?](https:\/\/covid19.trackvaccines.org\/covid-19-vaccine-development\/)\n  - [How are COVID-19 vaccines approved, including emergency use authorization?](https:\/\/covid19.trackvaccines.org\/vaccine-approval-and-eua\/)\n- [About](https:\/\/covid19.trackvaccines.org\/country\/france\/)\n  - [Data Sources](https:\/\/covid19.trackvaccines.org\/data-sources\/)\n  - [Our Team](https:\/\/covid19.trackvaccines.org\/our-team\/)\n  - [Press Room](https:\/\/covid19.trackvaccines.org\/press-room\/)\n  - [Contact Us](https:\/\/covid19.trackvaccines.org\/contact-us\/)\n\n- [Home](https:\/\/covid19.trackvaccines.org\/)\n- [Explore Vaccines](https:\/\/covid19.trackvaccines.org\/vaccines\/)\n  - [Approved Vaccines](https:\/\/covid19.trackvaccines.org\/vaccines\/approved\/)\n  - [Vaccine Candidates](https:\/\/covid19.trackvaccines.org\/vaccines\/)\n  - [Global Landscape](https:\/\/covid19.trackvaccines.org\/trials-vaccines-by-country\/)\n- [About Vaccines & Trials](https:\/\/covid19.trackvaccines.org\/country\/france\/)\n  - [How many types of COVID-19 vaccines are there?](https:\/\/covid19.trackvaccines.org\/vaccine-types\/)\n  - [How do COVID-19 vaccines work?](https:\/\/covid19.trackvaccines.org\/how-vaccines-work\/)\n  - [What are the benefits of COVID-19 vaccines?](https:\/\/covid19.trackvaccines.org\/benefits-of-vaccines\/)\n  - [What are the possible side effects of COVID-19 vaccines?](https:\/\/covid19.trackvaccines.org\/covid-19-vaccine-side-effects\/)\n  - [Do COVID-19 vaccines work against variants of concern?](https:\/\/covid19.trackvaccines.org\/voc\/)\n  - [Which COVID-19 vaccine should I get?](https:\/\/covid19.trackvaccines.org\/which-vaccine-to-get\/)\n  - [Do I need to get vaccinated if I’ve already had COVID-19?](https:\/\/covid19.trackvaccines.org\/already-had-covid-19\/)\n  - [How do I critically assess vaccine information?](https:\/\/covid19.trackvaccines.org\/heads\/)\n  - [How are vaccines tested?](https:\/\/covid19.trackvaccines.org\/how-are-vaccines-tested\/)\n  - [How is vaccine efficacy assessed?](https:\/\/covid19.trackvaccines.org\/vaccine-efficacy\/)\n  - [How were COVID-19 vaccines developed so quickly?](https:\/\/covid19.trackvaccines.org\/covid-19-vaccine-development\/)\n  - [How are COVID-19 vaccines approved, including emergency use authorization?](https:\/\/covid19.trackvaccines.org\/vaccine-approval-and-eua\/)\n- [About](https:\/\/covid19.trackvaccines.org\/country\/france\/)\n  - [Data Sources](https:\/\/covid19.trackvaccines.org\/data-sources\/)\n  - [Our Team](https:\/\/covid19.trackvaccines.org\/our-team\/)\n  - [Press Room](https:\/\/covid19.trackvaccines.org\/press-room\/)\n  - [Contact Us](https:\/\/covid19.trackvaccines.org\/contact-us\/)\n\n# France\n## 11 Vaccines Approved for Use in France\n- ## [Novavax Nuvaxovid](https:\/\/covid19.trackvaccines.org\/vaccines\/25\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 40 countries\n  **22 trials** in 14 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/nuvaxovid)\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Sanofi\/GSK VidPrevtyn Beta](https:\/\/covid19.trackvaccines.org\/vaccines\/165\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 30 countries\n  **3 trials** in 2 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-approval-vidprevtyn-beta-covid-19-booster-vaccine)\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Moderna Spikevax](https:\/\/covid19.trackvaccines.org\/vaccines\/22\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 88 countries\n  **70 trials** in 24 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Moderna Spikevax Bivalent Original\/Omicron BA.1](https:\/\/covid19.trackvaccines.org\/vaccines\/210\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 38 countries\n  **5 trials** in 4 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/news\/first-adapted-covid-19-booster-vaccines-recommended-approval-eu)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Moderna Spikevax Bivalent Original\/Omicron BA.4\/BA.5](https:\/\/covid19.trackvaccines.org\/vaccines\/224\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 33 countries\n  **2 trials** in 1 country\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Pfizer\/BioNTech Comirnaty](https:\/\/covid19.trackvaccines.org\/vaccines\/6\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 149 countries\n  **100 trials** in 31 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/comirnaty)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Pfizer\/BioNTech Comirnaty Bivalent Original\/Omicron BA.1](https:\/\/covid19.trackvaccines.org\/vaccines\/223\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 35 countries\n  **3 trials** in 5 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/news\/first-adapted-covid-19-booster-vaccines-recommended-approval-eu)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Pfizer\/BioNTech Comirnaty Bivalent Original\/Omicron BA.4\/BA.5](https:\/\/covid19.trackvaccines.org\/vaccines\/225\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 33 countries\n  **4 trials** in 1 country\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/news\/adapted-vaccine-targeting-ba4-ba5-omicron-variants-original-sars-cov-2-recommended-approval)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Janssen (Johnson & Johnson) Jcovden](https:\/\/covid19.trackvaccines.org\/vaccines\/1\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 113 countries\n  **26 trials** in 25 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/covid-19-vaccine-janssen)\n  [Non Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Oxford\/AstraZeneca Vaxzevria](https:\/\/covid19.trackvaccines.org\/vaccines\/4\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 149 countries\n  **73 trials** in 34 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vaxzevria-previously-covid-19-vaccine-astrazeneca)\n  [Non Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Valneva VLA2001](https:\/\/covid19.trackvaccines.org\/vaccines\/69\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 33 countries\n  **9 trials** in 4 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/covid-19-vaccine-inactivated-adjuvanted-valneva)\n  [Inactivated](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n## 6 Vaccines in Clinical Trials in France\n- ## [Sanofi\/GSK Recombinant Protein](https:\/\/covid19.trackvaccines.org\/vaccines\/34\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine has reached Phase 3 trials.\n  **6 trials** in 7 countries\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Sanofi\/GSK SP\/GSK subunit D614 vaccine](https:\/\/covid19.trackvaccines.org\/vaccines\/164\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine has reached Phase 3 trials.\n  **1 trial** in 1 country\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Sanofi\/GSK VidPrevtyn Beta](https:\/\/covid19.trackvaccines.org\/vaccines\/165\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 30 countries\n  **3 trials** in 2 countries\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Pfizer\/BioNTech Comirnaty](https:\/\/covid19.trackvaccines.org\/vaccines\/6\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 149 countries\n  **100 trials** in 31 countries\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Janssen (Johnson & Johnson) Jcovden](https:\/\/covid19.trackvaccines.org\/vaccines\/1\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine is approved.\n  **Approved** in 113 countries\n  **26 trials** in 25 countries\n  [Non Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [ReiThera GRAd-COV2](https:\/\/covid19.trackvaccines.org\/vaccines\/13\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine has reached Phase 3 trials.\n  **5 trials** in 12 countries\n  [Non Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n## 2 Vaccines with Trials in France are No Longer Progressing\n- ## [Curevac CVnCoV](https:\/\/covid19.trackvaccines.org\/vaccines\/11\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine has reached Phase 3 trials.\n  **9 trials** in 12 countries\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Institut Pasteur COVID-19-101](https:\/\/covid19.trackvaccines.org\/vaccines\/10\/)\n  - Phase 1\n  - Phase 2\n  - Phase 3\n  - Approved\n  This vaccine has reached Phase 1 trials.\n  **1 trial** in 2 countries\n  [Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n\n© 2026 [VIPER Group COVID19 Vaccine Tracker Team](https:\/\/covid19.trackvaccines.org\/ \"COVID19 Vaccine Tracker\")\n\nFunding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)\n\nThis site is provided for informational purposes only based on publically available data.\n\n[Site Credits](https:\/\/covid19.trackvaccines.org\/site-credits\/) \\| [Website Feedback Form](https:\/\/covid19.trackvaccines.org\/website-feedback\/)","attrs_readable_markdown":"## 11 Vaccines Approved for Use in France\n- ## [Novavax Nuvaxovid](https:\/\/covid19.trackvaccines.org\/vaccines\/25\/)\n  This vaccine is approved.\n  **Approved** in 40 countries\n  **22 trials** in 14 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/nuvaxovid)\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Sanofi\/GSK VidPrevtyn Beta](https:\/\/covid19.trackvaccines.org\/vaccines\/165\/)\n  This vaccine is approved.\n  **Approved** in 30 countries\n  **3 trials** in 2 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-approval-vidprevtyn-beta-covid-19-booster-vaccine)\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Moderna Spikevax](https:\/\/covid19.trackvaccines.org\/vaccines\/22\/)\n  This vaccine is approved.\n  **Approved** in 88 countries\n  **70 trials** in 24 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Moderna Spikevax Bivalent Original\/Omicron BA.1](https:\/\/covid19.trackvaccines.org\/vaccines\/210\/)\n  This vaccine is approved.\n  **Approved** in 38 countries\n  **5 trials** in 4 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/news\/first-adapted-covid-19-booster-vaccines-recommended-approval-eu)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Moderna Spikevax Bivalent Original\/Omicron BA.4\/BA.5](https:\/\/covid19.trackvaccines.org\/vaccines\/224\/)\n  This vaccine is approved.\n  **Approved** in 33 countries\n  **2 trials** in 1 country\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Pfizer\/BioNTech Comirnaty](https:\/\/covid19.trackvaccines.org\/vaccines\/6\/)\n  This vaccine is approved.\n  **Approved** in 149 countries\n  **100 trials** in 31 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/comirnaty)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Pfizer\/BioNTech Comirnaty Bivalent Original\/Omicron BA.1](https:\/\/covid19.trackvaccines.org\/vaccines\/223\/)\n  This vaccine is approved.\n  **Approved** in 35 countries\n  **3 trials** in 5 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/news\/first-adapted-covid-19-booster-vaccines-recommended-approval-eu)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Pfizer\/BioNTech Comirnaty Bivalent Original\/Omicron BA.4\/BA.5](https:\/\/covid19.trackvaccines.org\/vaccines\/225\/)\n  This vaccine is approved.\n  **Approved** in 33 countries\n  **4 trials** in 1 country\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/news\/adapted-vaccine-targeting-ba4-ba5-omicron-variants-original-sars-cov-2-recommended-approval)\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Janssen (Johnson & Johnson) Jcovden](https:\/\/covid19.trackvaccines.org\/vaccines\/1\/)\n  This vaccine is approved.\n  **Approved** in 113 countries\n  **26 trials** in 25 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/covid-19-vaccine-janssen)\n  [Non Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Oxford\/AstraZeneca Vaxzevria](https:\/\/covid19.trackvaccines.org\/vaccines\/4\/)\n  This vaccine is approved.\n  **Approved** in 149 countries\n  **73 trials** in 34 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vaxzevria-previously-covid-19-vaccine-astrazeneca)\n  [Non Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Valneva VLA2001](https:\/\/covid19.trackvaccines.org\/vaccines\/69\/)\n  This vaccine is approved.\n  **Approved** in 33 countries\n  **9 trials** in 4 countries\n  **Approval Source:** [ema.europa.eu](https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/covid-19-vaccine-inactivated-adjuvanted-valneva)\n  [Inactivated](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n## 6 Vaccines in Clinical Trials in France\n- ## [Sanofi\/GSK Recombinant Protein](https:\/\/covid19.trackvaccines.org\/vaccines\/34\/)\n  This vaccine has reached Phase 3 trials.\n  **6 trials** in 7 countries\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Sanofi\/GSK VidPrevtyn Beta](https:\/\/covid19.trackvaccines.org\/vaccines\/165\/)\n  This vaccine is approved.\n  **Approved** in 30 countries\n  **3 trials** in 2 countries\n  [Protein Subunit](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Pfizer\/BioNTech Comirnaty](https:\/\/covid19.trackvaccines.org\/vaccines\/6\/)\n  This vaccine is approved.\n  **Approved** in 149 countries\n  **100 trials** in 31 countries\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [Janssen (Johnson & Johnson) Jcovden](https:\/\/covid19.trackvaccines.org\/vaccines\/1\/)\n  This vaccine is approved.\n  **Approved** in 113 countries\n  **26 trials** in 25 countries\n  [Non Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n- ## [ReiThera GRAd-COV2](https:\/\/covid19.trackvaccines.org\/vaccines\/13\/)\n  This vaccine has reached Phase 3 trials.\n  **5 trials** in 12 countries\n  [Non Replicating Viral Vector](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)\n## 2 Vaccines with Trials in France are No Longer Progressing\n- ## [Curevac CVnCoV](https:\/\/covid19.trackvaccines.org\/vaccines\/11\/)\n  This vaccine has reached Phase 3 trials.\n  **9 trials** in 12 countries\n  [RNA](https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/)","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

2 days ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0.1 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://covid19.trackvaccines.org/country/france/
Last Crawled	2026-04-09 19:49:35 (2 days ago)
First Indexed	2021-01-14 14:03:36 (5 years ago)
HTTP Status Code	200
Meta Title	France – COVID19 Vaccine Tracker
Meta Description	null
Meta Canonical	null
Boilerpipe Text	11 Vaccines Approved for Use in France Novavax Nuvaxovid This vaccine is approved. Approved in 40 countries 22 trials in 14 countries Approval Source: ema.europa.eu Protein Subunit Sanofi/GSK VidPrevtyn Beta This vaccine is approved. Approved in 30 countries 3 trials in 2 countries Approval Source: ema.europa.eu Protein Subunit Moderna Spikevax This vaccine is approved. Approved in 88 countries 70 trials in 24 countries Approval Source: ema.europa.eu RNA Moderna Spikevax Bivalent Original/Omicron BA.1 This vaccine is approved. Approved in 38 countries 5 trials in 4 countries Approval Source: ema.europa.eu RNA Moderna Spikevax Bivalent Original/Omicron BA.4/BA.5 This vaccine is approved. Approved in 33 countries 2 trials in 1 country Approval Source: ema.europa.eu RNA Pfizer/BioNTech Comirnaty This vaccine is approved. Approved in 149 countries 100 trials in 31 countries Approval Source: ema.europa.eu RNA Pfizer/BioNTech Comirnaty Bivalent Original/Omicron BA.1 This vaccine is approved. Approved in 35 countries 3 trials in 5 countries Approval Source: ema.europa.eu RNA Pfizer/BioNTech Comirnaty Bivalent Original/Omicron BA.4/BA.5 This vaccine is approved. Approved in 33 countries 4 trials in 1 country Approval Source: ema.europa.eu RNA Janssen (Johnson & Johnson) Jcovden This vaccine is approved. Approved in 113 countries 26 trials in 25 countries Approval Source: ema.europa.eu Non Replicating Viral Vector Oxford/AstraZeneca Vaxzevria This vaccine is approved. Approved in 149 countries 73 trials in 34 countries Approval Source: ema.europa.eu Non Replicating Viral Vector Valneva VLA2001 This vaccine is approved. Approved in 33 countries 9 trials in 4 countries Approval Source: ema.europa.eu Inactivated 6 Vaccines in Clinical Trials in France Sanofi/GSK Recombinant Protein This vaccine has reached Phase 3 trials. 6 trials in 7 countries Protein Subunit Sanofi/GSK VidPrevtyn Beta This vaccine is approved. Approved in 30 countries 3 trials in 2 countries Protein Subunit Pfizer/BioNTech Comirnaty This vaccine is approved. Approved in 149 countries 100 trials in 31 countries RNA Janssen (Johnson & Johnson) Jcovden This vaccine is approved. Approved in 113 countries 26 trials in 25 countries Non Replicating Viral Vector ReiThera GRAd-COV2 This vaccine has reached Phase 3 trials. 5 trials in 12 countries Non Replicating Viral Vector 2 Vaccines with Trials in France are No Longer Progressing Curevac CVnCoV This vaccine has reached Phase 3 trials. 9 trials in 12 countries RNA
Markdown	[Skip to Content](https://covid19.trackvaccines.org/country/france/#content) This site is no longer being updated. Data are accurate as of 2 Dec 2022. [![COVID-19 Vaccine Tracker](https://covid19.trackvaccines.org/wp-content/uploads/2020/09/new-logo-draft.png)](https://covid19.trackvaccines.org/) Menu - [Home](https://covid19.trackvaccines.org/) - [Explore Vaccines](https://covid19.trackvaccines.org/vaccines/) - [Approved Vaccines](https://covid19.trackvaccines.org/vaccines/approved/) - [Vaccine Candidates](https://covid19.trackvaccines.org/vaccines/) - [Global Landscape](https://covid19.trackvaccines.org/trials-vaccines-by-country/) - [About Vaccines & Trials](https://covid19.trackvaccines.org/country/france/) - [How many types of COVID-19 vaccines are there?](https://covid19.trackvaccines.org/vaccine-types/) - [How do COVID-19 vaccines work?](https://covid19.trackvaccines.org/how-vaccines-work/) - [What are the benefits of COVID-19 vaccines?](https://covid19.trackvaccines.org/benefits-of-vaccines/) - [What are the possible side effects of COVID-19 vaccines?](https://covid19.trackvaccines.org/covid-19-vaccine-side-effects/) - [Do COVID-19 vaccines work against variants of concern?](https://covid19.trackvaccines.org/voc/) - [Which COVID-19 vaccine should I get?](https://covid19.trackvaccines.org/which-vaccine-to-get/) - [Do I need to get vaccinated if I’ve already had COVID-19?](https://covid19.trackvaccines.org/already-had-covid-19/) - [How do I critically assess vaccine information?](https://covid19.trackvaccines.org/heads/) - [How are vaccines tested?](https://covid19.trackvaccines.org/how-are-vaccines-tested/) - [How is vaccine efficacy assessed?](https://covid19.trackvaccines.org/vaccine-efficacy/) - [How were COVID-19 vaccines developed so quickly?](https://covid19.trackvaccines.org/covid-19-vaccine-development/) - [How are COVID-19 vaccines approved, including emergency use authorization?](https://covid19.trackvaccines.org/vaccine-approval-and-eua/) - [About](https://covid19.trackvaccines.org/country/france/) - [Data Sources](https://covid19.trackvaccines.org/data-sources/) - [Our Team](https://covid19.trackvaccines.org/our-team/) - [Press Room](https://covid19.trackvaccines.org/press-room/) - [Contact Us](https://covid19.trackvaccines.org/contact-us/) - [Home](https://covid19.trackvaccines.org/) - [Explore Vaccines](https://covid19.trackvaccines.org/vaccines/) - [Approved Vaccines](https://covid19.trackvaccines.org/vaccines/approved/) - [Vaccine Candidates](https://covid19.trackvaccines.org/vaccines/) - [Global Landscape](https://covid19.trackvaccines.org/trials-vaccines-by-country/) - [About Vaccines & Trials](https://covid19.trackvaccines.org/country/france/) - [How many types of COVID-19 vaccines are there?](https://covid19.trackvaccines.org/vaccine-types/) - [How do COVID-19 vaccines work?](https://covid19.trackvaccines.org/how-vaccines-work/) - [What are the benefits of COVID-19 vaccines?](https://covid19.trackvaccines.org/benefits-of-vaccines/) - [What are the possible side effects of COVID-19 vaccines?](https://covid19.trackvaccines.org/covid-19-vaccine-side-effects/) - [Do COVID-19 vaccines work against variants of concern?](https://covid19.trackvaccines.org/voc/) - [Which COVID-19 vaccine should I get?](https://covid19.trackvaccines.org/which-vaccine-to-get/) - [Do I need to get vaccinated if I’ve already had COVID-19?](https://covid19.trackvaccines.org/already-had-covid-19/) - [How do I critically assess vaccine information?](https://covid19.trackvaccines.org/heads/) - [How are vaccines tested?](https://covid19.trackvaccines.org/how-are-vaccines-tested/) - [How is vaccine efficacy assessed?](https://covid19.trackvaccines.org/vaccine-efficacy/) - [How were COVID-19 vaccines developed so quickly?](https://covid19.trackvaccines.org/covid-19-vaccine-development/) - [How are COVID-19 vaccines approved, including emergency use authorization?](https://covid19.trackvaccines.org/vaccine-approval-and-eua/) - [About](https://covid19.trackvaccines.org/country/france/) - [Data Sources](https://covid19.trackvaccines.org/data-sources/) - [Our Team](https://covid19.trackvaccines.org/our-team/) - [Press Room](https://covid19.trackvaccines.org/press-room/) - [Contact Us](https://covid19.trackvaccines.org/contact-us/) # France ## 11 Vaccines Approved for Use in France - ## [Novavax Nuvaxovid](https://covid19.trackvaccines.org/vaccines/25/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 40 countries 22 trials in 14 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/nuvaxovid) [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Sanofi/GSK VidPrevtyn Beta](https://covid19.trackvaccines.org/vaccines/165/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 30 countries 3 trials in 2 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/news/ema-recommends-approval-vidprevtyn-beta-covid-19-booster-vaccine) [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Moderna Spikevax](https://covid19.trackvaccines.org/vaccines/22/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 88 countries 70 trials in 24 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Moderna Spikevax Bivalent Original/Omicron BA.1](https://covid19.trackvaccines.org/vaccines/210/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 38 countries 5 trials in 4 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/news/first-adapted-covid-19-booster-vaccines-recommended-approval-eu) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Moderna Spikevax Bivalent Original/Omicron BA.4/BA.5](https://covid19.trackvaccines.org/vaccines/224/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 33 countries 2 trials in 1 country Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Pfizer/BioNTech Comirnaty](https://covid19.trackvaccines.org/vaccines/6/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 149 countries 100 trials in 31 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Pfizer/BioNTech Comirnaty Bivalent Original/Omicron BA.1](https://covid19.trackvaccines.org/vaccines/223/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 35 countries 3 trials in 5 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/news/first-adapted-covid-19-booster-vaccines-recommended-approval-eu) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Pfizer/BioNTech Comirnaty Bivalent Original/Omicron BA.4/BA.5](https://covid19.trackvaccines.org/vaccines/225/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 33 countries 4 trials in 1 country Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/news/adapted-vaccine-targeting-ba4-ba5-omicron-variants-original-sars-cov-2-recommended-approval) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Janssen (Johnson & Johnson) Jcovden](https://covid19.trackvaccines.org/vaccines/1/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 113 countries 26 trials in 25 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen) [Non Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Oxford/AstraZeneca Vaxzevria](https://covid19.trackvaccines.org/vaccines/4/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 149 countries 73 trials in 34 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca) [Non Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Valneva VLA2001](https://covid19.trackvaccines.org/vaccines/69/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 33 countries 9 trials in 4 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-inactivated-adjuvanted-valneva) [Inactivated](https://covid19.trackvaccines.org/types-of-vaccines/) ## 6 Vaccines in Clinical Trials in France - ## [Sanofi/GSK Recombinant Protein](https://covid19.trackvaccines.org/vaccines/34/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine has reached Phase 3 trials. 6 trials in 7 countries [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Sanofi/GSK SP/GSK subunit D614 vaccine](https://covid19.trackvaccines.org/vaccines/164/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine has reached Phase 3 trials. 1 trial in 1 country [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Sanofi/GSK VidPrevtyn Beta](https://covid19.trackvaccines.org/vaccines/165/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 30 countries 3 trials in 2 countries [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Pfizer/BioNTech Comirnaty](https://covid19.trackvaccines.org/vaccines/6/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 149 countries 100 trials in 31 countries [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Janssen (Johnson & Johnson) Jcovden](https://covid19.trackvaccines.org/vaccines/1/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine is approved. Approved in 113 countries 26 trials in 25 countries [Non Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [ReiThera GRAd-COV2](https://covid19.trackvaccines.org/vaccines/13/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine has reached Phase 3 trials. 5 trials in 12 countries [Non Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) ## 2 Vaccines with Trials in France are No Longer Progressing - ## [Curevac CVnCoV](https://covid19.trackvaccines.org/vaccines/11/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine has reached Phase 3 trials. 9 trials in 12 countries [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Institut Pasteur COVID-19-101](https://covid19.trackvaccines.org/vaccines/10/) - Phase 1 - Phase 2 - Phase 3 - Approved This vaccine has reached Phase 1 trials. 1 trial in 2 countries [Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) © 2026 [VIPER Group COVID19 Vaccine Tracker Team](https://covid19.trackvaccines.org/ "COVID19 Vaccine Tracker") Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4) This site is provided for informational purposes only based on publically available data. [Site Credits](https://covid19.trackvaccines.org/site-credits/) \\| [Website Feedback Form](https://covid19.trackvaccines.org/website-feedback/)
Readable Markdown	## 11 Vaccines Approved for Use in France - ## [Novavax Nuvaxovid](https://covid19.trackvaccines.org/vaccines/25/) This vaccine is approved. Approved in 40 countries 22 trials in 14 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/nuvaxovid) [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Sanofi/GSK VidPrevtyn Beta](https://covid19.trackvaccines.org/vaccines/165/) This vaccine is approved. Approved in 30 countries 3 trials in 2 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/news/ema-recommends-approval-vidprevtyn-beta-covid-19-booster-vaccine) [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Moderna Spikevax](https://covid19.trackvaccines.org/vaccines/22/) This vaccine is approved. Approved in 88 countries 70 trials in 24 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Moderna Spikevax Bivalent Original/Omicron BA.1](https://covid19.trackvaccines.org/vaccines/210/) This vaccine is approved. Approved in 38 countries 5 trials in 4 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/news/first-adapted-covid-19-booster-vaccines-recommended-approval-eu) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Moderna Spikevax Bivalent Original/Omicron BA.4/BA.5](https://covid19.trackvaccines.org/vaccines/224/) This vaccine is approved. Approved in 33 countries 2 trials in 1 country Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Pfizer/BioNTech Comirnaty](https://covid19.trackvaccines.org/vaccines/6/) This vaccine is approved. Approved in 149 countries 100 trials in 31 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Pfizer/BioNTech Comirnaty Bivalent Original/Omicron BA.1](https://covid19.trackvaccines.org/vaccines/223/) This vaccine is approved. Approved in 35 countries 3 trials in 5 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/news/first-adapted-covid-19-booster-vaccines-recommended-approval-eu) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Pfizer/BioNTech Comirnaty Bivalent Original/Omicron BA.4/BA.5](https://covid19.trackvaccines.org/vaccines/225/) This vaccine is approved. Approved in 33 countries 4 trials in 1 country Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/news/adapted-vaccine-targeting-ba4-ba5-omicron-variants-original-sars-cov-2-recommended-approval) [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Janssen (Johnson & Johnson) Jcovden](https://covid19.trackvaccines.org/vaccines/1/) This vaccine is approved. Approved in 113 countries 26 trials in 25 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen) [Non Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Oxford/AstraZeneca Vaxzevria](https://covid19.trackvaccines.org/vaccines/4/) This vaccine is approved. Approved in 149 countries 73 trials in 34 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca) [Non Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Valneva VLA2001](https://covid19.trackvaccines.org/vaccines/69/) This vaccine is approved. Approved in 33 countries 9 trials in 4 countries Approval Source: [ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-inactivated-adjuvanted-valneva) [Inactivated](https://covid19.trackvaccines.org/types-of-vaccines/) ## 6 Vaccines in Clinical Trials in France - ## [Sanofi/GSK Recombinant Protein](https://covid19.trackvaccines.org/vaccines/34/) This vaccine has reached Phase 3 trials. 6 trials in 7 countries [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Sanofi/GSK VidPrevtyn Beta](https://covid19.trackvaccines.org/vaccines/165/) This vaccine is approved. Approved in 30 countries 3 trials in 2 countries [Protein Subunit](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Pfizer/BioNTech Comirnaty](https://covid19.trackvaccines.org/vaccines/6/) This vaccine is approved. Approved in 149 countries 100 trials in 31 countries [RNA](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [Janssen (Johnson & Johnson) Jcovden](https://covid19.trackvaccines.org/vaccines/1/) This vaccine is approved. Approved in 113 countries 26 trials in 25 countries [Non Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) - ## [ReiThera GRAd-COV2](https://covid19.trackvaccines.org/vaccines/13/) This vaccine has reached Phase 3 trials. 5 trials in 12 countries [Non Replicating Viral Vector](https://covid19.trackvaccines.org/types-of-vaccines/) ## 2 Vaccines with Trials in France are No Longer Progressing - ## [Curevac CVnCoV](https://covid19.trackvaccines.org/vaccines/11/) This vaccine has reached Phase 3 trials. 9 trials in 12 countries [RNA](https://covid19.trackvaccines.org/types-of-vaccines/)
Shard	165 (laksa)
Root Hash	5896860197286366765
Unparsed URL	org,trackvaccines!covid19,/country/france/ s443